• ChemFaces is a professional high-purity natural products manufacturer.
  • Product Intended Use
  • 1. Reference standards
  • 2. Pharmacological research
  • 3. Inhibitors
  • Home
  • Natural Products
  • Bioactive
  • Screening Libraries
  • Hot Products
  • Plant Catalog
  • Customer Support
  • Product Use Citation
  • About Us
  • Contact Us
  • Natural Products
    Cimifugin
    Information
    CAS No. 37921-38-3 Price $100 / 20mg
    Catalog No.CFN98612Purity>=98%
    Molecular Weight306.3 Type of CompoundFlavonoids
    FormulaC16H18O6Physical DescriptionPowder
    Download Manual    COA    MSDSSimilar structuralComparison (Web)
    Citing Use of our Products
    How to Order
    Orders via your E-mail:

    1. Product number / Name / CAS No.
    2. Delivery address
    3. Ordering/billing address
    4. Contact information
    Sent to Email: info@chemfaces.com
    Contact Us
    Order & Inquiry & Tech Support

    Tel: (0086)-27-84237683
    Fax: (0086)-27-84254680
    E-mail: manager@chemfaces.com
    Address: No. 83, CheCheng Rd., WETDZ, Wuhan, Hubei 430056, PRC
    Delivery time
    Delivery & Payment method

    1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

    2. We accept: Wire transfer & Credit card & Paypal & Western Union
    * Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
    According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
    Size /Price /Stock 10 mM * 1 mL in DMSO / $51.8 / In-stock
    Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
    Our products had been exported to the following research institutions and universities, And still growing.
  • Chang Gung University (Taiwan)
  • University of Stirling (United Kingdom)
  • University of Pretoria (South Africa)
  • University of Bonn (Germany)
  • University of Auckland (New Zealand)
  • University of Canterbury (New Zealand)
  • University of Vigo (Spain)
  • University of Zurich (Switzerland)
  • Leibniz-Institut für Pflanzenb... (Germany)
  • University of Maryland (USA)
  • University of Amsterdam (Netherlands)
  • More...
  • Package
    Featured Products
    Ganoderol A

    Catalog No: CFN99065
    CAS No: 104700-97-2
    Price: $488/5mg
    Norwogonin

    Catalog No: CFN92218
    CAS No: 4443-09-8
    Price: $388/10mg
    3,6'-Disinapoyl sucrose

    Catalog No: CFN90578
    CAS No: 139891-98-8
    Price: $138/20mg
    Linderane

    Catalog No: CFN98175
    CAS No: 13476-25-0
    Price: $138/20mg
    (-)-Pinoresinol

    Catalog No: CFN92287
    CAS No: 81446-29-9
    Price: $268/5mg
    Syringaresinol-di-O-glucoside

    Catalog No: CFN90458
    CAS No: 66791-77-3
    Price: $288/20mg
    Ginsenoside Rg5

    Catalog No: CFN92643
    CAS No: 186763-78-0
    Price: $168/10mg
    Related Screening Libraries
    Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
    10 mM * 1 mL in DMSO / Inquiry / In-stock
    Related Libraries
  • Inhibitors Compound Library
  • Anti-contact dermatitis Compound Library
  • Flavonoids Compound Library
  • IL Receptor Inhibitor Library
  • IFN-γ Inhibitor Library
  • AChR Inhibitor Library
  • Biological Activity
    Description: Cimifugin evidently inhibits FITC-induced type 2 allergic contact dermatitis,and its mechanism might related to regulating the balance of Th1 /Th2 by inhibiting type 2 cytokines. Cimifugin displayed low to moderate inhibition towards AChE and BChE (3.12 and 21.63%, respectively) at 200 ug/mL.
    Targets: IFN-γ | IL Receptor | AChR | BChR
    In vivo:
    Pharmacol. Clin. Chinese Mat. Med., 2014, 30(2):28-30.
    Cimifugin inhibits allergic contact dermatitis by regulating type 2 cytokines.[Reference: WebLink]
    This study was carried out to investigate the effective and mechanism of Cimifugin on type 2 allergic contact dermatitis induced by FITC.
    METHODS AND RESULTS:
    The BALB /c mice were sensitized with FITC on days 1 and 2,on the shaved abdomen skin. On day 6,the animals were challenged on their right ears with FITC. Simultaneously,the mice were administered Cimifugin from day 1 to day 5. On day 7,ear swelling was measured and the infiltration of lymphocytic was investigated by hematoxylin and eosin( HE) staining. The levels of IL-4,IL-9,IL-13 and IFN-γ were quantified by ELISA and BCA. The results suggested that mouse ear swelling was dramatically inhibited by25 mg /kg,50 mg /kg Cimifugin. Histopathological results indicated that mice given Cimifugin has significant improvement on local tissue fluid exudation,congestion,and lymphocytic infiltration was remarkably reduced by Cimifugin. At the same time type 2 cytokines IL-4,IL-9,IL-13in the mouse ear tissue homogenate were obviously reduced by Cimifugin,while no significant changes with type 1 cytokines IFN-γ.
    CONCLUSIONS:
    Cimifugin evidently inhibited FITC-induced type 2 allergic contact dermatitis,and its mechanism might related to regulating the balance of Th1 /Th2 by inhibiting type 2 cytokines.
    Cimifugin Description
    Source: The roots of Saposhnikovia divaricata (Turcz.) Schischk.
    Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
    Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

    Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

    Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

    After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
    Recent ChemFaces New Products and Compounds
    7-Hydroxyaristolochic acid A

    Catalog No: CFN90517
    CAS No: 79185-75-4
    Price: $220/5mg
    Tectoruside

    Catalog No: CFN95051
    CAS No: 38784-73-5
    Price: $288/20mg
    Scopolin

    Catalog No: CFN98887
    CAS No: 531-44-2
    Price: $168/20mg
    Bryonamide A

    Catalog No: CFN91056
    CAS No: 75268-14-3
    Price: $268/5mg
    Bruceoside A

    Catalog No: CFN95080
    CAS No: 63306-30-9
    Price: $318/5mg
    20-O-Glucoginsenoside Rf

    Catalog No: CFN95036
    CAS No: 68406-27-9
    Price: $368/10mg
    Oroselol

    Catalog No: CFN95001
    CAS No: 1891-25-4
    Price: $358/5mg
    Caraganaphenol A

    Catalog No: CFN95093
    CAS No: 174916-31-5
    Price: $333/5mg
    Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    Calculate Dilution Ratios(Only for Reference)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 3.2648 mL 16.3239 mL 32.6477 mL 65.2955 mL 81.6193 mL
    5 mM 0.653 mL 3.2648 mL 6.5295 mL 13.0591 mL 16.3239 mL
    10 mM 0.3265 mL 1.6324 mL 3.2648 mL 6.5295 mL 8.1619 mL
    50 mM 0.0653 mL 0.3265 mL 0.653 mL 1.3059 mL 1.6324 mL
    100 mM 0.0326 mL 0.1632 mL 0.3265 mL 0.653 mL 0.8162 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    Protocol
    Kinase Assay:
    Natural Product Communications, 2016, 11(8).
    Development of an Efficient Protocol for Cimifugin Isolation from Peucedanum schottii and Evaluation of Enzyme Inhibitory Activity.[Reference: WebLink]

    METHODS AND RESULTS:
    The dichloromethane extract of the fruits of Peucedanum schotti Besser ex DC. (Apiaceae) was subjected to high-performance counter-current chromatography (HPCCC) for the efficient and fast separation (30 min) and subsequent isolation of Cimifugin using ethyl acetate: water (1:1 v/v, K = 1.01) system. Separation was further optimized on analytical scale and then easy up-scaled to semipreparative conditions. A total of 135 mg of Cimifugin (96.5% purity) was purified from 1.2 g of the dichloromethane extract (11.25% yield). Cimifugin was isolated for the first time from P. schotti and characterized by NMR spectroscopy. Further Cimifugin, along with the crude extract were evaluated for their inhibitory potential against cholinesterases (acetylcholinesterase - AChE and butyrylcholinesterase - BChE) and tyrosinase (TYR), key enzymes for the treatment of some neurodegenerative diseases, i.e. Alzheimer’s and Parkinson’s, using ELISA microtiter assays.
    CONCLUSIONS:
    The crude extract exhibited a weak inhibitory activity against AChE, BChE, and TYR (4.19, 35.47, and 0% at 100 μg mL-1 and 10.26, 40.03, and 12.25% at 200 μg mL-1, respectively), while Cimifugin displayed low to moderate inhibition towards AChE and BChE (3.12 and 21.63%, respectively) at 200 μg mL-1.
    Structure Identification:
    Biomed Chromatogr. 2012 Oct;26(10):1234-40.
    Comparative pharmacokinetics of prim-O-glucosylcimifugin and cimifugin by liquid chromatography-mass spectrometry after oral administration of Radix Saposhnikoviae extract, cimifugin monomer solution and prim-O-glucosylcimifugin monomer solution to rats.[Pubmed: 22253022]
    A sensitive and reliable liquid chromatography-mass spectrometry method has been developed and validated for simultaneous determination of Cimifugin and prim-O-glucosylCimifugin in rat plasma after oral administration of Radix Saposhnikoviae (RS) extract, prim-O-glucosylCimifugin monomer solution and Cimifugin monomer solution.
    METHODS AND RESULTS:
    Plasma samples were pretreated by protein precipitation with acetonitrile containing the internal standards puerarin and daidzein. LC separation was achieved on a Zorbax SB-C(18) column (150 × 4.6 mm i.d., 5 μm) with 0.1% formic acid in water and methanol by isocratic elution. The detection was carried out in select-ion-monitoring mode with a positive electrospray ionization interface. The fully validated method was successfully applied to the pharmacokinetic study of the analytes in rats. A bimodal phenomenon appeared in the concentration-time curve of prim-O-glucosylCimifugin and Cimifugin after oral administration of RS extract. Prim-O-glucosylCimifugin mainly transformed to Cimifugin when it was absorbed into blood. Both absorption and elimination of Cimifugin after oral administration of RS were longer than after administration of single Cimifugin.
    CONCLUSIONS:
    The pharmacokinetic parameters (AUC(0-t) , AUC(0-∞) and t(1/2) ) of prim-O-glucosylCimifugin and Cimifugin by giving Cimifugin monomer solution, prim-O-glucosylCimifugin monomer solution and RS extract had significant differences (P < 0.05).